Skip to main content
. 2011 Jan;101(1):101–111. doi: 10.2105/AJPH.2009.175331

TABLE 1.

Demographic, Clinical, and Risk Factor Characteristics of Tuberculosis (TB) Patients, by Birth Country and Ethnicity: United States, 2000–2007

Foreign-Born Filipinos (n = 7 038), No. (%) Other Foreign-Born APIs (n = 19 559), No. (%) US-Born Non-Hispanic Whites (n = 18 907), No. (%)
Age at diagnosis, y
    > 44 4 306 (61.2) 9 323 (47.7) 14 042 (74.3)
    ≤ 44 2 731 (38.8) 10 233 (52.3) 4 862 (25.7)
Age at entry into the United States, ya
    > 44 2 379 (33.8) 14 641 (74.9) NA
    ≤ 44 4 659 (66.2) 4 918 (25.1) NA
Residence in the United States, y
    < 2 3 107 (44.1) 8 099 (41.4) NA
    2–5 648 (9.2) 2 376 (12.1) NA
    > 5 3 283 (46.6) 9 084 (46.4) NA
Gender
    Female 3 250 (46.2) 8 728 (45.6) 6 174 (32.7)
    Male 3 787 (53.8) 10 829 (55.4) 12 729 (67.3)
Mortality at diagnosis
    Deceased 68 (1.0) 244 (1.2) 763 (4.0)
    Living 6 969 (99.0) 19 305 (98.7) 18 136 (95.9)
Type of TB disease
    Extrapulmonary 1 380 (19.6) 5 441 (27.8) 2 655 (14.0)
    Extrapulmonary and pulmonary 415 (5.9) 1 511 (7.7) 1 140 (6.0)
    Pulmonary 5 241 (74.5) 12 601 (64.4) 15 101 (79.9)
Chest radiograph result
    Abnormal 5 946 (84.5) 15 521 (79.4) 16 919 (89.5)
    Normal 964 (13.7) 3 604 (18.4) 1 468 (7.8)
Cavitation on chest radiographb
Cavitary 1 214 (20.8) 3 010 (19.9) 4 811 (29.0)
    Noncavitary, consistent with TB 4 312 (73.7) 11 090 (73.3) 10 138 (61.2)
    Noncavitary, not consistent with TB 254 (4.3) 795 (5.3) 1 302 (7.9)
Drug resistancec
    INH monoresistance 718 (13.0) 1 670 (10.7) 511 (3.5)
    RIF monoresistance 10 (0.2) 43 (0.3) 52 (0.4)
    INH and RIF resistance (multidrug resistance) 92 (1.7) 315 (2.0) 59 (0.4)
    Susceptible to INH and RIF 4 700 (85.1) 13 563 (87.0) 13 826 (95.7)
Sputum smear test
    Positive 2 009 (28.6) 6 066 (31.0) 7 188 (38.0)
    Not done 1 196 (17.0) 4 286 (21.9) 4 354 (23.0)
    Negative 3 809 (54.1) 9 133 (46.7) 7 282 (38.5)
Therapyd
    Any DOT 4 848 (70.2) 13 035 (68.2) 13 876 (77.1)
    Self-therapy style 1 493 (21.6) 4 292 (22.4) 2 976 (16.6)
Completed therapyd
    Yes 3 947 (82.4) 10 872 (81.8) 10 436 (83.5)
    No 841 (17.6) 2 423 (18.2) 2 060 (16.5)
Outcomed
    Died 306 (4.4) 888 (4.6) 2 081 (11.6)
    Lost to follow-up 73 (1.1) 351 (1.8) 214 (1.2)
    Moved 270 (3.9) 644 (3.4) 161 (0.9)
    Completed 5 563 (80.5) 14 961 (78.2) 13 796 (76.7)
Provider typee
    Private 1 848 (26.5) 4 559 (23.6) 3 971 (21.9)
    Public 4 544 (65.3) 12 923 (66.9) 12 993 (71.6)
HIV statusf
    Positive 27 (0.8) 191 (1.6) 796 (4.8)
    Refused 295 (9.0) 1 783 (15.2) 1 783 (10.7)
    Not offered 751 (23.0) 2 210 (18.9) 3 665 (22.0)
    Negative 1 906 (58.4) 6 585 (56.3) 9 288 (55.7)
Homeless in past 12 mo
    Yes 48 (0.7) 174 (0.9) 1 864 (9.9)
    No 6 938 (98.6) 19 121 (97.8) 16 882 (89.3)
Resident of correctional facility
    Yes 18 (0.3) 109 (0.6) 606 (3.2)
    No 7 010 (99.6) 19 427 (99.3) 18 280 (96.7)
Resident of long-term health care facility
    Yes 82 (1.2) 217 (1.1) 1 116 (5.9)
    No 6 944 (98.7) 19 314 (98.7) 17 763 (93.9)
Occupation in past 24 mog
    Health care worker 647 (9.2) 481 (2.5) 460 (2.4)
    Migrant worker 14 (0.2) 15 (0.1) 14 (0.1)
    Unemployed 1 748 (24.8) 5 780 (29.6) 5 055 (26.7)
    Other employment 2 589 (36.8) 8169 (41.8) 5 485 (29.0)
Excessive alcohol use
    Yes 273 (3.9) 571 (2.9) 3 907 (20.7)
    No 6 531 (92.8) 18 597 (95.1) 14 450 (76.4)
Injection drug use
    Yes 8 (0.1) 38 (0.2) 573 (3.0)
    No 6 777 (96.3) 19 148 (97.9) 17 753 (93.9)
Noninjection drug use
    Yes 56 (0.8) 141 (0.7) 1 587 (8.4)
    No 6 708 (95.3) 19 012 (97.2) 16 686 (88.3)
Previous TB diagnosis
    Yes 473 (6.7) 1 233 (6.3) 1 010 (5.3)
    No 6 499 (92.3) 18 133 (92.7) 17 751 (93.9)

Note. API = Asian/Pacific Islander; DOT = directly observed therapy; INH = isoniazid; NA = not applicable; RIF = rifampin.

a

Median age of entry into the United States was age 37 years for Filippinos, and age 31 years for other APIs.

b

Analysis limited to TB patients with abnormal X-ray results: Filipinos (n = 5 780); other APIs (n = 14 895); US-born non-Hispanic Whites (n = 16 251); patients with these data unknown or missing were not included.

c

Analysis limited to culture-positive TB patients with isolates that had susceptibility testing performed: Filipinos (n = 5 520); other APIs (n = 15 591); US-born non-Hispanic Whites (n = 14 448); patients with these data unknown or missing were not included.

d

Analysis limited to patients registered in the National Tuberculosis Surveillance System from 2000 to 2005 who were alive at diagnosis and started drug therapy: Filipinos (n = 6 341); other APIs (n = 17 327); US-born non-Hispanic Whites (n = 16 852); patients with these data unknown or missing were not included.

e

Analysis limited to patients who were alive at diagnosis: Filipinos (n = 6 392); other APIs (n = 17 482); US-born non-Hispanic Whites (n = 16 964); patients with these data unknown or missing were not included.

f

Analysis limited to patients registered in the National Tuberculosis Surveillance System from all states excluding California and Vermont: Filipinos (n = 2 979); other APIs (n = 10 769); US-born non-Hispanic Whites (n = 15 532); patients with these data unknown or missing were not included.

g

Patients aged younger than 16 years or older than 65 years included in analysis as a separate group, not eligible for employment (results not shown).